NormOxys Raises $17.5M in Series B Financing
NormOxys, Inc., a Wellesley, MA-based biotechnology company developing a novel class of small molecule drugs which enhance the body’s ability to deliver oxygen to diseased tissues, has raised $17.5m in a Series B financing round. The financing was led by a new investor, Care Capital, LLC, with participation from existing venture investor Index Ventures. This […]